The US Food and Drug Administration has approved lenacapavir, a drug that offers 100% protection against HIV with twice-yearly injections. Sold under the brand name Yeztugo, lenacapavir is a capsid inhibitor. It stops the virus from entering cells and copying itself.
Gilead has made moves to ensure the drug is affordable — eligible uninsured individuals will likely be able to access the drug free of cost through its Advancing Access medication assistance program.
Read the article on New Atlas.
Sources:
• TLDR. (2025, July 28). TLDR Newsletter. https://a.tldrnewsletter.com/web-version?ep=1&lc=f5cb7e17-003d-11ed-9258-0241b9615763&p=0c8d1bfa-6b7a-11f0-b570-1bc256a52ca6&pt=campaign&t=1753700258&s=5186faf8c30198787abbfe20d57e76d057fd2225c63ef5c50360b501b72650da
• Thompson, B. (2025, July 26). The first 100% effective HIV prevention drug is approved and going global. New Atlas. https://newatlas.com/infectious-diseases/hiv-prevention-fda-lenacapavir/
